Doximity reports news about its digital platform for U.S. medical professionals, including tools for clinical collaboration, medical news and research, career and on-call management, documentation workflows, and virtual patient visits. Company updates commonly cover quarterly financial results, platform engagement, workflow products, and AI-powered clinical reference and search capabilities.
Recurring developments also include Doximity Dialer telehealth recognition, physician research on AI adoption, and the integration of Pathway Medical into Doximity's clinical reference offerings. The company's news flow links product expansion with its verified medical-professional network and its role in digital workflow tools built for physicians.
Doximity (NYSE: DOCS) announced their Q4 and Fiscal Year 2024 financial results. For the fiscal year, total revenues reached $475.4 million, a 13% increase year-over-year, and net income grew by 31%. Q4 revenues were $118.1 million, showing a 6% increase. Adjusted EBITDA for the fiscal year rose by 25%, and net income margins improved from 26.9% to 31%. The company reported a diluted net income per share for the fiscal year of $0.72, up from $0.53. Doximity also introduced a $500 million stock repurchase program. The company's financial outlook for fiscal year 2025 includes revenues between $506 million and $518 million, and adjusted EBITDA between $238 million and $250 million.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.